These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 24183378

  • 1. Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells.
    Fan P, Agboke FA, McDaniel RE, Sweeney EE, Zou X, Creswell K, Jordan VC.
    Eur J Cancer; 2014 Jan; 50(2):457-68. PubMed ID: 24183378
    [Abstract] [Full Text] [Related]

  • 2. A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer.
    Fan P, Agboke FA, Cunliffe HE, Ramos P, Jordan VC.
    Eur J Cancer; 2014 Nov; 50(16):2866-76. PubMed ID: 25204804
    [Abstract] [Full Text] [Related]

  • 3. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
    Chan CM, Martin LA, Johnston SR, Ali S, Dowsett M.
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
    [Abstract] [Full Text] [Related]

  • 4. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
    Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.
    Breast Cancer Res; 2008 Aug; 10(6):R104. PubMed ID: 19061505
    [Abstract] [Full Text] [Related]

  • 5. c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells.
    Fan P, Griffith OL, Agboke FA, Anur P, Zou X, McDaniel RE, Creswell K, Kim SH, Katzenellenbogen JA, Gray JW, Jordan VC.
    Cancer Res; 2013 Jul 15; 73(14):4510-20. PubMed ID: 23704208
    [Abstract] [Full Text] [Related]

  • 6. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
    Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL.
    Breast Cancer Res; 2013 Jul 15; 15(4):R55. PubMed ID: 23844554
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cells.
    Sweeney EE, Fan P, Jordan VC.
    Int J Oncol; 2014 May 15; 44(5):1529-38. PubMed ID: 24604139
    [Abstract] [Full Text] [Related]

  • 8. Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.
    Fan P, McDaniel RE, Kim HR, Clagett D, Haddad B, Jordan VC.
    Eur J Cancer; 2012 Dec 15; 48(18):3488-98. PubMed ID: 22658320
    [Abstract] [Full Text] [Related]

  • 9. Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells.
    Fan P, Cunliffe HE, Griffith OL, Agboke FA, Ramos P, Gray JW, Jordan VC.
    Eur J Cancer; 2014 Nov 15; 50(16):2877-86. PubMed ID: 25212499
    [Abstract] [Full Text] [Related]

  • 10. Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
    Guest SK, Ribas R, Pancholi S, Nikitorowicz-Buniak J, Simigdala N, Dowsett M, Johnston SR, Martin LA.
    PLoS One; 2016 Nov 15; 11(6):e0157397. PubMed ID: 27308830
    [Abstract] [Full Text] [Related]

  • 11. Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.
    Song RX, Chen Y, Zhang Z, Bao Y, Yue W, Wang JP, Fan P, Santen RJ.
    J Steroid Biochem Mol Biol; 2010 Feb 28; 118(4-5):219-30. PubMed ID: 19815064
    [Abstract] [Full Text] [Related]

  • 12. The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling.
    Martin LA, Pancholi S, Chan CM, Farmer I, Kimberley C, Dowsett M, Johnston SR.
    Endocr Relat Cancer; 2005 Dec 28; 12(4):1017-36. PubMed ID: 16322340
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
    Liu X, Feng R.
    Acta Biochim Biophys Sin (Shanghai); 2010 Jul 28; 42(7):496-501. PubMed ID: 20705589
    [Abstract] [Full Text] [Related]

  • 14. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
    Chiu JH, Wen CS, Wang JY, Hsu CY, Tsai YF, Hung SC, Tseng LM, Shyr YM.
    J Transl Med; 2017 May 04; 15(1):97. PubMed ID: 28472954
    [Abstract] [Full Text] [Related]

  • 15. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.
    Azar ZM, Mehdi MZ, Srivastava AK.
    Can J Physiol Pharmacol; 2006 Jul 04; 84(7):777-86. PubMed ID: 16998541
    [Abstract] [Full Text] [Related]

  • 16. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
    Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC.
    J Natl Cancer Inst; 2005 Dec 07; 97(23):1746-59. PubMed ID: 16333030
    [Abstract] [Full Text] [Related]

  • 17. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K.
    Breast Cancer Res Treat; 2006 Oct 07; 99(3):275-88. PubMed ID: 16752221
    [Abstract] [Full Text] [Related]

  • 18. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM, Bernaciak TM, Wen J, Weaver AM, Shupnik MA, Silva CM.
    Mol Endocrinol; 2008 Aug 07; 22(8):1781-96. PubMed ID: 18550772
    [Abstract] [Full Text] [Related]

  • 19. Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer Cells.
    Fan P, Cunliffe HE, Maximov PY, Agboke FA, McDaniel RE, Zou X, Ramos P, Russell ML, Jordan VC.
    Mol Cancer Res; 2015 Oct 07; 13(10):1367-76. PubMed ID: 26116171
    [Abstract] [Full Text] [Related]

  • 20. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Ungefroren H, Sebens S, Groth S, Gieseler F, Fändrich F.
    Curr Cancer Drug Targets; 2011 May 07; 11(4):524-35. PubMed ID: 21395548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.